Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Inv. presentation
Quarterly results
Achaogen Inc (AKAO) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/29/2019 8-K Quarterly results
07/23/2019 8-K Acquisition/merger/asset purchase announced
Docs: "Amendment No. 1 to the Asset Purchase Agreement, by and between Achaogen, Inc. and Cipla USA Inc (Schedules and exhibits have been omitted from this exhibit pursuant to Item 601(b)(2) of Regulation S-K and are not filed herewith. The registrant hereby agrees to furnish a copy of any omitted schedule or exhibits to the U.S. Securities and Exchange Commission upon request)"
06/28/2019 8-K Quarterly results
06/26/2019 8-K Quarterly results
06/07/2019 8-K Other Events, Financial Statements and Exhibits
Docs: "Achaogen, Inc. Announces Results of Auction for Substantially All Company Assets"
06/05/2019 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Monthly Operating Report"
05/06/2019 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure...
Docs: "Initial Monthly Operating Report"
04/23/2019 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events
04/22/2019 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Senior Secured Superpriority Debtor-in-Possession Loan and Security Agreement between the Company and Silicon Valley Bank",
"Intellectual Property Security Agreement between the Company and Silicon Valley Bank"
04/18/2019 8-K Entry into a Material Definitive Agreement, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an...
Docs: "Waiver and First Amendment to the Loan and Security Agreement, by and between the Company and Silicon Valley Bank",
"Intellectual Property Security Agreement, by and between the Company and Silicon Valley Bank"
04/15/2019 8-K Bankruptcy or Receivership, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listi...
Docs: "Achaogen Plans for Near-Term Sale Using Structured Process Through Chapter 11 of the U.S. Bankruptcy Code"
04/08/2019 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Departure of Directors o...
03/28/2019 8-K Quarterly results
Docs: "Achaogen Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update"
03/06/2019 8-K Cost Associated with Exit or Disposal Activities
02/20/2019 8-K Quarterly results
02/14/2019 8-K Quarterly results
11/08/2018 8-K Quarterly results
Docs: "ZEMDRI Launch Update: The launch focus continues to be the education of physicians on the clinical profile of ZEMDRI and building the foundation to support product use across the hospital and outpatient settings. The commercial organization continues to build momentum on key leading indicators including: formulary review and approval, orders of antibiotic susceptibility testing materials and customer readiness for therapeutic drug management testing. ZEMDRI revenues for the quarter represent approximately two months of product sales prior to broad formulary approval or the availability of the NTAP supplementary reimbursement, which went into effect on October 1st. During the quarter, ZEMDRI achieved net revenues of $291,000 and, to date, 60% of use has been in the outpatient setting. &#x20..."
11/02/2018 8-K Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial ...
10/17/2018 8-K Quarterly results
09/17/2018 8-K/A Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "8-K/A"
08/06/2018 8-K Quarterly results
Docs: "Achaogen Reports Second Quarter 2018 Financial Results and Provides Corporate Update"
07/26/2018 8-K Cost Associated with Exit or Disposal Activities, Departure of Directors or Certain Officers; Election of Directors; Appointm...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report : July 26, 2018 ACHAOGEN, INC. Delaware 001-36323 68-0533693 1 Tower Place, Suite 300 South San Francisco, CA 94080 Registrant's telephone number, including area code: 800-3636"
06/26/2018 8-K Other Events
Docs: "FORM 8-K"
06/07/2018 8-K Submission of Matters to a Vote of Security Holders
Docs: "FORM 8-K"
05/04/2018 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report : May 4, 2018 ACHAOGEN, INC. Delaware 001-36323 68-0533693 1 Tower Place, Suite 300 South San Francisco, CA 94080 Registrant's telephone number, including area code: 800-3636 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) ☐ Pre-commencement communic...",
"Recent Highlights and Upcoming Milestones"
02/27/2018 8-K Quarterly results
Docs: "Achaogen Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update"
01/30/2018 8-K Other Events, Financial Statements and Exhibits
Docs: "Exhibit 99.1 Achaogen Announces Upgraded Status for Plazomicin Fill Manufacturer"
01/11/2018 8-K Investor presentation
Docs: "J.P. Morgan Healthcare Conference Presentation",
"Corporate Presentation"
12/11/2017 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
11/08/2017 8-K Quarterly results
Docs: "Achaogen Reports Third Quarter 2017 Financial Results and Provides Corporate Update"
08/03/2017 8-K Quarterly results
08/02/2017 8-K/A Quarterly results
07/26/2017 8-K Form 8-K - Current report:
07/13/2017 8-K Form 8-K - Current report:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy